Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 520

    1.

    Clinical manifestations and treatment of retinoblastoma in Korea.

    Chung SE, Sa HS, Koo HH, Yoo KH, Sung KW, Ham DI.

    Br J Ophthalmol. 2008 Sep;92(9):1180-4. Epub 2008 Jul 23.PMID: 18650212 [PubMed - indexed for MEDLINE]Related articles

    2.

    Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.

    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.

    Ophthalmology. 2004 Oct;111(10):1917-24.PMID: 15465557 [PubMed - indexed for MEDLINE]Related articles

    3.

    Treatment of intraocular retinoblastoma with vincristine and carboplatin.

    Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB.

    J Clin Oncol. 2003 May 15;21(10):2019-25.PMID: 12743157 [PubMed - indexed for MEDLINE]Related articles

    4.

    Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.

    Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA.

    Ophthalmology. 2009 Mar;116(3):544-551.e1. Epub 2009 Jan 20.PMID: 19157557 [PubMed - indexed for MEDLINE]Related articles

    5.

    Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.

    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.

    Trans Am Ophthalmol Soc. 2004;102:35-44; discussion 44-5.PMID: 15747743 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.

    Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT.

    Ophthalmology. 1997 Dec;104(12):2101-11.PMID: 9400771 [PubMed - indexed for MEDLINE]Related articles

    7.

    Chemoreduction for unilateral retinoblastoma.

    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ.

    Arch Ophthalmol. 2002 Dec;120(12):1653-8.PMID: 12470138 [PubMed - indexed for MEDLINE]Related articles

    8.

    The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.

    Gündüz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, Needle M.

    Arch Ophthalmol. 1998 Dec;116(12):1613-7.PMID: 9869790 [PubMed - indexed for MEDLINE]Related articles

    9.

    Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.

    Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.

    Pediatr Blood Cancer. 2008 Mar;50(3):567-72.PMID: 17729249 [PubMed - indexed for MEDLINE]Related articles

    10.

    The success of primary chemotherapy for group D heritable retinoblastoma.

    Cohen VM, Kingston J, Hungerford JL.

    Br J Ophthalmol. 2009 Jul;93(7):887-90. Epub 2008 Aug 14.PMID: 18703556 [PubMed - indexed for MEDLINE]Related articles

    11.

    Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.

    Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G.

    Med Pediatr Oncol. 2002 Jun;38(6):411-5.PMID: 11984802 [PubMed - indexed for MEDLINE]Related articles

    12.

    Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.

    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.

    Am J Ophthalmol. 2002 May;133(5):657-64.PMID: 11992863 [PubMed - indexed for MEDLINE]Related articles

    13.

    Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.

    Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG.

    Ophthalmology. 2007 Jan;114(1):162-9. Epub 2006 Oct 27.PMID: 17070578 [PubMed - indexed for MEDLINE]Related articles

    14.

    The International Classification of Retinoblastoma predicts chemoreduction success.

    Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA.

    Ophthalmology. 2006 Dec;113(12):2276-80. Epub 2006 Sep 25.PMID: 16996605 [PubMed - indexed for MEDLINE]Related articles

    15.

    Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.

    Demirci H, Eagle RC Jr, Shields CL, Shields JA.

    Arch Ophthalmol. 2003 Aug;121(8):1125-31.PMID: 12912690 [PubMed - indexed for MEDLINE]Related articles

    16.

    Clinical result of prolonged primary chemotherapy in retinoblastoma patients.

    Kim JH, Yu YS, Khwarg SI, Choi HS, Shin HY, Ahn HS.

    Korean J Ophthalmol. 2003 Jun;17(1):35-43.PMID: 12882506 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.

    Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M.

    Br J Ophthalmol. 2009 Jan;93(1):28-32. Epub 2008 Oct 24.PMID: 18952647 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma]

    Balwierz W, Kobylarz J, Starzycka M, Dluzniewska A.

    Med Wieku Rozwoj. 2001 Jul-Sep;5(3 Suppl 1):15-23. Polish. PMID: 12004148 [PubMed - indexed for MEDLINE]Related articles

    19.

    Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.

    Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ.

    Arch Ophthalmol. 2002 Apr;120(4):460-4.PMID: 11934319 [PubMed - indexed for MEDLINE]Related articles

    20.

    Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.

    Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA.

    Arch Ophthalmol. 2005 Jun;123(6):765-73.PMID: 15955977 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data